Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norditropin SimpleXx Acceptance in Children
NCT00567385Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Mar 2003
- Primary completion
- Mar 2004
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of somatropin in growth hormone deficiency (GHD), Turner syndrome (TS), chronic kidney disease (CKD), sponsored by Novo Nordisk. Started Mar 2003; status: completed.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)Turner syndrome (TS)chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT00567385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00567385.